Novartis India to pursue therapy-aligned acquisitions; eyes expansion in Tier 2 and Tier 3 markets

Novartis India plans acquisitions and deeper market penetration for future growth. The company will focus on five key therapy areas for expansion. Established brands will be brought under full commercial control by 2026-27. Rising chronic diseases and an aging population drive sustained therapy demand. Improved insurance and healthcare infrastructure will unlock new patient demand.